Add to ORKGPropranolol, valproic acid, and amitriptyline are effective prophylaxis for migraine in children to varying degrees, are widely available, and have a reasonable safety profile (strength of recommendation [SOR]: B, based on either single randomized controlled trial, prospective or retrospective cohort studies, or trials with conflicting evidence). Flunarizine and nimodipine have the best evidence of benefit in children; however, availability, cost, and side effects limit their usefulness (SOR: B, based on multiple small randomized controlled trials)
Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine...
Objectives: 1) To describe the state of the evidence for interventions in pediatric migraine, 2) to ...
Background: Migraine is a common health problem in children and adolescents. This study compares the...
The aim of this study was to assess the efficacy of pharmacological prophylactic treatments of migra...
Preventive therapy for migraine headache includes identification of migraine precipitants, possible ...
Migraine is one of the most common neurologic disorders in children and adolescents. However, a quan...
Objective: No drugs have been approved for pediatric migraine prophylaxis by the Food and Drug Admin...
Objective: The objective of this selective EBM review is to determine whether or not “Is amitriptyli...
Beta-blockers without intrinsic sympathomimetic activity, amitriptyline, divalproex sodium/sodium va...
Introduction: Migraine is the most frequent and most important headache in childhood. Therefore, pro...
headaches in children and adolescents. Amitriptyline efficacy as a prophylactic treatment for migrai...
Migraine is the most common cause of acute recurrent headaches in children. The pathophysiological c...
For this narrative review, we found recent publications on the use and effectiveness of old therapie...
Migraine prevalence in childhood ranges from 2.7 to 10% causing a significant impact on quality of l...
The appropriate treatment of migraine requires an individually tailored approach and is based on bio...
Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine...
Objectives: 1) To describe the state of the evidence for interventions in pediatric migraine, 2) to ...
Background: Migraine is a common health problem in children and adolescents. This study compares the...
The aim of this study was to assess the efficacy of pharmacological prophylactic treatments of migra...
Preventive therapy for migraine headache includes identification of migraine precipitants, possible ...
Migraine is one of the most common neurologic disorders in children and adolescents. However, a quan...
Objective: No drugs have been approved for pediatric migraine prophylaxis by the Food and Drug Admin...
Objective: The objective of this selective EBM review is to determine whether or not “Is amitriptyli...
Beta-blockers without intrinsic sympathomimetic activity, amitriptyline, divalproex sodium/sodium va...
Introduction: Migraine is the most frequent and most important headache in childhood. Therefore, pro...
headaches in children and adolescents. Amitriptyline efficacy as a prophylactic treatment for migrai...
Migraine is the most common cause of acute recurrent headaches in children. The pathophysiological c...
For this narrative review, we found recent publications on the use and effectiveness of old therapie...
Migraine prevalence in childhood ranges from 2.7 to 10% causing a significant impact on quality of l...
The appropriate treatment of migraine requires an individually tailored approach and is based on bio...
Migraine involves 5-10% of children and adolescents. Thirty percent of children with severe migraine...
Objectives: 1) To describe the state of the evidence for interventions in pediatric migraine, 2) to ...
Background: Migraine is a common health problem in children and adolescents. This study compares the...